FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 312:270-276 January 31, 1985 Number 5 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We assessed the presence of hepatitis B virus (HBV) DNA in liver or serum samples from 134 patients with hepatitis B surface antigen (HBsAg)-negative chronic liver disease, including 20 with hepatocellular carcinoma. HBV DNA sequences were detected in 52 of the 88 liver samples (59 per cent), including 17 of the 20 samples from patients with hepatocellular carcinoma. Presumably "replicative forms" of HBV DNA were detected in only 5 of the 88 liver samples, 3 of which were from patients with no serologic marker for HBV. In most of the liver samples the DNA patterns were consistent with the presence of HBV or a closely related virus. Of the 105 serum samples tested, HBV DNA sequences were identified in 10 (9.5 per cent), 6 of which had no HBV serologic marker. Moreover, HBsAg-associated determinants were detected in 5 of 17 patients who were positive for HBV DNA and in none of 14 patients who were negative. This study demonstrates the high frequency of HBsAg-negative HBV DNA-positive viral infection of the liver and suggests that multiplication of HBV may occur in the absence of any conventional serologic marker for HBV.

This article has been cited by other articles:

• Ikeda, K., Marusawa, H., Osaki, Y., Nakamura, T., Kitajima, N., Yamashita, Y., Kudo, M., Sato, T., Chiba, T. (2007). Antibody to Hepatitis B Core Antigen and Risk for Hepatitis C-Related Hepatocellular Carcinoma: A Prospective Study. ANN INTERN MED 146: 649-656 [Abstract] [Full Text]  
• Kao, J.-H., Chen, P.-J., Lai, M.-Y., Chen, D.-S. (2002). Occult Hepatitis B Virus Infection and Clinical Outcomes of Patients with Chronic Hepatitis C. J. Clin. Microbiol. 40: 4068-4071 [Abstract] [Full Text]  
• Hennig, H., Puchta, I., Luhm, J., Schlenke, P., Goerg, S., Kirchner, H. (2002). Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 100: 2637-2641 [Abstract] [Full Text]  
• Weber, B., Bayer, A., Kirch, P., Schlüter, V., Schlieper, D., Melchior, W. (1999). Improved Detection of Hepatitis B Virus Surface Antigen by a New Rapid Automated Assay. J. Clin. Microbiol. 37: 2639-2647 [Abstract] [Full Text]  
• Marusawa, H, Osaki, Y, Kimura, T, Ito, K, Yamashita, Y, Eguchi, T, Kudo, M, Yamamoto, Y, Kojima, H, Seno, H, Moriyasu, F, Chiba, T (1999). High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 45: 284-288 [Abstract] [Full Text]  
• Sloand, E. M., Pitt, E., Klein, H. G. (1995). Safety of the Blood Supply. JAMA 274: 1368-1373 [Abstract]  
• Draelos, M., Morgan, T., Schifman, R. B., Sampliner, R. E. (1987). Significance of Isolated Antibody to Hepatitis B Core Antigen Determined by Immune Response to Hepatitis B Vaccination. JAMA 258: 1193-1195 [Abstract]  
• KOZIOL, D. E., HOLLAND, P. V., ALLING, D. W., MELPOLDER, J. C., SOLOMON, R. E., PURCELL, R. H., HUDSON, L. M., SHOUP, F. J., KRAKAUER, H., ALTER, H. J. (1986). Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood. ANN INTERN MED 104: 488-495 [Abstract]